Art

J-GLOBAL ID：202102274561882855   Reference number：21A0188177

Phase II trial of combination treatment with S-1/cetuximab in patients with platinum-ineligible recurrent and/or metastatic squamous cell carcinoma of the head and neck

プラチナ製剤投与不能患者や頭頸部転移性扁平上皮癌患者におけるS-1/セツキシマブ併用治療の第II相試験

Author (17)： Taguchi Jun (Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan) ,  Shimizu Yasushi (Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan) ,  Ariga Shin (Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan) ,  Goda Tomohiro (Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan) ,  Ohhara Yoshihito (Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan) ,  Honma Rio (Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan) ,  Noguchi Takuro (Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan) ,  Takeuchi Satoshi (Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan) ,  Kinoshita Ichiro (Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan) ,  Amano Toraji (Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan) ,  Amano Toraji (Hokkaido University Hospital Clinical Research and Medical Innovation Center, Sapporo, Japan) ,  Mizumachi Takatsugu (Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan) ,  Kano Satoshi (Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan) ,  Takahara Miki (Department of Otolaryngology Head and Neck Surgery, Asahikawa Medical University, Asahikawa, Japan) ,  Abe Takahisa (Department of Otolaryngology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan) ,  Homma Akihiro (Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan) ,  Dosaka-Akita Hirotoshi (Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan)
Material： International Journal of Clinical Oncology (Web)
Volume： 26  Issue： 1  Page： 51-58  Publication year： 2021 
JST Material Number： U1599A  ISSN： 1341-9625  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： *Cetuximab ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A0188177&from=J-GLOBAL&jstjournalNo=U1599A") }}

Author keywords (6)： S-1 ,  Cetuximab ,  Head and neck ,  Recurrent ,  Metastatic ,  Squamous cell carcinoma

JST classification (2)： Clinical application of antitumor(=antineoplastic)drugs  (GW16020L) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Substance index (1)： TS-1

Terms in the title (9)： プラチナ製剤 ,  投与 ,  患者 ,  頭頸部 ,  転移性扁平上皮癌 ,  S-1 ,  セツキシマブ ,  併用治療 ,  第II相試験